EBV infection
Clinical trials for EBV infection explained in plain language.
Never miss a new study
Get alerted when new EBV infection trials appear
Sign up with your email to follow new studies for EBV infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A new attack on Epstein-Barr fatigue: two capsules put to the test
Disease control Recruiting nowThis trial tests whether two experimental capsules, 2LEBV and 2LXFS, can reduce fatigue and other symptoms in people with an Epstein-Barr virus infection. Participants take one capsule daily for six months, either one of the study drugs or a placebo. The study measures changes in…
Matched conditions: EBV INFECTION
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Immune cells engineered to hunt viruses show promise for transplant kids
Disease control Recruiting nowThis study tests a new cell therapy called LB-DTK-MV in children aged 1-25 who have stubborn viral infections (CMV, EBV, or BKV) after a stem cell transplant. The therapy uses specially grown immune cells from a donor to attack the viruses. Participants receive two infusions two …
Matched conditions: EBV INFECTION
Sponsor: LucasBio • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Donor cells take on Drug-Resistant viruses in new trial
Disease control Recruiting nowThis early-phase trial tests a treatment called LB-DTK-MV, which uses immune cells from a healthy donor to fight three viruses (CMV, BKV, and EBV) that have become resistant to standard antiviral drugs. The study includes 27 adults who have had a stem cell transplant or certain c…
Matched conditions: EBV INFECTION
Phase 1/2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a safer drug replace standard antiviral for kidney transplant patients?
Disease control Recruiting nowThis study tests if valacyclovir works as well as valganciclovir to prevent CMV and EBV infections in kidney transplant patients. Valganciclovir can cause bone marrow suppression, a serious side effect. The study will enroll 80 kidney transplant recipients and monitor them for ne…
Matched conditions: EBV INFECTION
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Scientists seek tissue samples to unlock HIV and cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from people with HIV, KSHV, or certain cancers to help researchers learn more about these diseases. Participants must be 18 or older and may have HIV, KSHV, or related conditions. No treatment is given; the goal is to gat…
Matched conditions: EBV INFECTION
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC